1. Academic Validation
  2. A small-molecule dye for NIR-II imaging

A small-molecule dye for NIR-II imaging

  • Nat Mater. 2016 Feb;15(2):235-42. doi: 10.1038/nmat4476.
Alexander L Antaris 1 2 Hao Chen 1 3 Kai Cheng 3 Yao Sun 1 Guosong Hong 2 Chunrong Qu 1 Shuo Diao 2 Zixin Deng 1 Xianming Hu 1 Bo Zhang 2 Xiaodong Zhang 2 Omar K Yaghi 2 Zita R Alamparambil 2 Xuechuan Hong 1 Zhen Cheng 3 Hongjie Dai 2
Affiliations

Affiliations

  • 1 State Key Laboratory of Virology, Key Laboratory of Combinatorial Biosynthesis and Drug Discovery (Wuhan University), Ministry of Education, Wuhan University School of Pharmaceutical Sciences, Wuhan 430071, China.
  • 2 Department of Chemistry, Stanford University, California 94305, USA.
  • 3 Molecular Imaging Program at Stanford (MIPS), Bio-X Program, and Department of Radiology, Canary Center at Stanford for Cancer Early Detection, Stanford University, California 94305-5344, USA.
Abstract

Fluorescent imaging of biological systems in the second near-infrared window (NIR-II) can probe tissue at centimetre depths and achieve micrometre-scale resolution at depths of millimetres. Unfortunately, all current NIR-II fluorophores are excreted slowly and are largely retained within the reticuloendothelial system, making clinical translation nearly impossible. Here, we report a rapidly excreted NIR-II fluorophore (∼90% excreted through the kidneys within 24 h) based on a synthetic 970-Da organic molecule (CH1055). The fluorophore outperformed indocyanine green (ICG)-a clinically approved NIR-I dye-in resolving mouse lymphatic vasculature and sentinel lymphatic mapping near a tumour. High levels of uptake of PEGylated-CH1055 dye were observed in brain tumours in mice, suggesting that the dye was detected at a depth of ∼4 mm. The CH1055 dye also allowed targeted molecular imaging of tumours in vivo when conjugated with anti-EGFR Affibody. Moreover, a superior tumour-to-background signal ratio allowed precise image-guided tumour-removal surgery.

Figures
Products